CIK 0001858848
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tenaya Therapeutics, Inc.
Sign in to watch- Ticker
- TNYA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813789973
- Phone
- +1 415-865-2066
- Business address
- 171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series A Preferred Stock | −3,727,742 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series A Preferred Stock | −4,209,755 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series B Preferred Stock | −472,659 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series B Preferred Stock | −533,781 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series C Preferred Stock | −188,881 | 0 | ||
| 2021-08-03 | GOEDDEL DAVID V Director | Conversion · Series C Preferred Stock | −213,306 | 0 | ||
| 2021-08-03 | Kang JeenJoo Director | Conversion | +12,500 | 25,000 | ||
| 2021-08-03 | Kang JeenJoo Director | Conversion · Series A Preferred Stock | −12,500 | 0 |
Page 12 of 12 · 228 trades